UK to receive further 2m doses of Moderna’s COVID vaccine candidate

Moderna has announced a supply agreement with the UK government for an additional 2 million doses of its COVID-19 vaccine candidate, mRNA-1273, to the UK beginning in March 2021.

The UK government has now secured 7 million doses of mRNA-1273. This confirmation comes as the UK continues its efforts to secure access to safe and effective COVID-19 vaccines by establishing a broad portfolio of the most promising vaccines.

“We appreciate the collaboration with the UK government as with many other governments and other key partners around the world,” said Moderna CEO Stéphane Bancel.

“For almost a decade, Moderna has invested in creating and developing a novel platform for designing and manufacturing a new class of mRNA-based vaccines. We are proud of the progress on mRNA-1273 we have made to date including the positive interim analysis from our Phase 3 COVE study.”

Last month, Moderna announced that its vaccine candidate achieved 95% efficiency in the COVE study.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site but journalism costs money and we rely on advertising and digital revenues to help to support them.

With the Covid-19 lockdown having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites with a small donation of even £1, your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

In the meantime may I wish you the very best.

- Advertisement -

Related news